Innovation Pharmaceuticals Receives Data Supporting Brilacidin’s Direct Inhibition of SARS-CoV-2, the Novel Coronavirus Responsible for COVID-19
April 01, 2020 08:21 ET
|
Innovation Pharmaceuticals Inc.
WAKEFIELD, Mass., April 01, 2020 (GLOBE NEWSWIRE) -- Innovation Pharmaceuticals (OTCQB:IPIX) (“the Company”), a clinical stage biopharmaceutical company, announced today it has received data...
Call Volume to Senior Living Communities Increases 200% Due to Pandemic
March 27, 2020 06:55 ET
|
SeniorVu
Kansas City, Mo., March 27, 2020 (GLOBE NEWSWIRE) -- Limited visits to senior living communities across the country by family members who want to check on their loved ones means the phones are...
Essential Partners offers free virtual dialogue series to combat COVID-19 social isolation
March 26, 2020 15:04 ET
|
Essential Partners
Cambridge, MA, March 26, 2020 (GLOBE NEWSWIRE) -- As officials across the United States extend the timeline for social distancing, Essential Partners (EP), a Cambridge-based nonprofit, is offering a...
Weigh Risks and Benefits of COVID-19 Response, Advises Association of American Physicians and Surgeons (AAPS)
March 21, 2020 13:16 ET
|
Association of American Physicians and Surgeons
TUCSON, Ariz., March 21, 2020 (GLOBE NEWSWIRE) -- A new group called US Healthcare Providers for Federal Action Against COVID-19 has launched a petition on change.org calling for an immediate...
Innovation Pharmaceuticals Brilacidin to be Researched as Possible Novel Coronavirus (COVID-19) Vaccine; Brilacidin Now Being Tested as Drug and Vaccine at Different Institutions
March 17, 2020 07:30 ET
|
Innovation Pharmaceuticals Inc.
WAKEFIELD, Mass., March 17, 2020 (GLOBE NEWSWIRE) -- Innovation Pharmaceuticals (OTCQB:IPIX) (“the Company”), a clinical stage biopharmaceutical company, announced today further details on the...
Innovation Pharmaceuticals Announces Testing Procedures of Brilacidin Against Coronavirus (COVID-19)
March 12, 2020 08:00 ET
|
Innovation Pharmaceuticals Inc.
WAKEFIELD, Mass., March 12, 2020 (GLOBE NEWSWIRE) -- Innovation Pharmaceuticals (OTCQB:IPIX) (“the Company”), a clinical stage biopharmaceutical company, announced today research procedures that one...
Freedom Needed to Combat Coronavirus, States Association of American Physicians and Surgeons (AAPS)
March 10, 2020 15:20 ET
|
Association of American Physicians and Surgeons
TUCSON, Ariz., March 10, 2020 (GLOBE NEWSWIRE) -- The coronavirus pandemic shows the effect of government interference with free-market solutions, states the Association of American Physicians and...
U.S. Regional Biocontainment Lab to Begin Testing of Brilacidin Against Coronavirus (COVID-19) Next Week
March 10, 2020 08:20 ET
|
Innovation Pharmaceuticals Inc.
WAKEFIELD, Mass., March 10, 2020 (GLOBE NEWSWIRE) -- Innovation Pharmaceuticals (OTCQB:IPIX) (“the Company”), a clinical stage biopharmaceutical company, is pleased to inform shareholders that...
Global Mice Model Market worth 1,370.5 million USD by 2023
July 23, 2018 08:44 ET
|
Meticulous Market Research Pvt. Ltd.
LONDON, July 23, 2018 (GLOBE NEWSWIRE) -- According to the latest publication from Meticulous Research®, the global mice model market is expected to reach USD 1,370.5 million by 2023, at a CAGR of...
![Water Missions International logo](/news-release/logo/311747/0/311747.jpg?lastModified=12%2F10%2F2016%2002%3A48%3A26&size=2)
Ebola-stricken Community in Liberia Receives Safe Water through Charleston based Non-Profit, Water Missions International
September 22, 2014 20:09 ET
|
Water Missions International
CHARLESTON, S.C., Sept. 22, 2014 (GLOBE NEWSWIRE) -- As the international response to the Ebola outbreak in West Africa continues to ramp up, Water Missions International (WMI), a non-profit Christian...